openPR Logo
Press release

Anti-PD-1 MAb Market - Demand And Segments, Size Analysis Forecast to 2028

07-03-2023 12:40 PM CET | Health & Medicine

Press release from: The Insight Partners

The immune system has an important ability to differentiate between normal cells in the body from those it sees as "foreign." This helps the immune system attack foreign cells without harming the normal cells by using "checkpoints." Immune checkpoints are molecules on specific immune cells that must be activated (or inactivated) to start an immune response. Cancer cells use these checkpoints to avoid immune system attacks on them. Certain drugs that target these checkpoints are called checkpoint inhibitors. These drugs target cell surface checkpoint proteins to stimulate the recognition and destruction of cancer cells by the immune system. PD-1 is a checkpoint protein on immune cells called T cells. Programmed cell death protein 1(PD-1) inhibitors are a group of checkpoint inhibitor anticancer drugs that block the activity of PD-1 immune checkpoint proteins present on the surface of cells. Anti-PD-1 monoclonal antibodies block the PD-1 receptor, so the T cells are no longer inhibited and activate the immune response against the tumor.

Download Sample Brochure at: https://www.theinsightpartners.com/sample/TIPRE00023269/?utm_source=OpenPR&utm_medium=10766

Market Dynamics:

Drivers

• The increasing prevalence of cancer and growing awareness of checkpoint inhibitors drive the anti-PD-1 MAb market.
• The rising adoption of pembrolizumab and nivolumab and increasing geriatric population boost the market growth.
• Technological advancements in screening procedures for cancer, rising healthcare expenditures, and growing government initiatives to alleviate cancer fuel the market growth.

Restraints

• High cost associated with research activities.

Market Segmentation:

• Based on product, the global anti-PD-1 MAb market is segmented into 40mg, 100mg, 200mg and others.
• On the basis of application, the market is bifurcated into melanoma patients, lung cancer patients, lymphoma patients and other.

Competitive Analysis:

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2023 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anti-PD-1 MAb market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anti-PD-1 MAb market in these regions.

Companies Profiled in this report includes:

The report covers key developments in the anti-PD-1 MAb market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from anti-PD-1 MAb market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-PD-1 MAb in the global market.

• Merck
• Junshi Pharma
• Coherus BioSciences
• Bristol Myers Squibb
• TopAlliance Biosciences Co., Ltd.
• Selleck Chemicals
• Aditya Pharma
• Beijing Beigene
• Genentech
• Innovent Biologics Inc

Speak to Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00023269/?utm_source=OpenPR&utm_medium=10766

The scope of the Report:

The "Global Anti-PD-1 MAb Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the anti-PD-1 MAb market with detailed market segmentation by product, application, and geography. The report provides key statistics on the market status of the leading anti-PD-1 MAb market players and offers key trends and opportunities in the market.

Buy Report at: https://www.theinsightpartners.com/buy/TIPRE00023269/?utm_source=OpenPR&utm_medium=10766

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-PD-1 MAb Market - Demand And Segments, Size Analysis Forecast to 2028 here

News-ID: 3110567 • Views:

More Releases from The Insight Partners

Global Blood Cancer Drugs Market Outlook: Growth at 7% CAGR
Global Blood Cancer Drugs Market Outlook: Growth at 7% CAGR
New York, US - October 22, 2025 - The Blood Cancer Drugs Market is poised for robust growth, projected to expand at a CAGR of around 7% from 2025 to 2031, driven by continued advancements in targeted therapy, immuno-oncology, and patient-centered treatment models. As research deepens into leukemia, lymphoma, and myeloma, precision medicine and cell-based therapies are reshaping global cancer care. Get Sample PDF:- https://www.theinsightpartners.com/sample/TIPRE00019607?utm_source=Openpr&utm_medium=10392 The market's evolution is marked not just
Aircraft MRO Market Accelerates Toward 2031
Aircraft MRO Market Accelerates Toward 2031
New York, US - October 22, 2025 - The global aircraft MRO (maintenance, repair, and operations) market is on the cusp of remarkable change. Leading aviation stakeholders, from service providers to airlines, are responding rapidly to post-pandemic recovery, technological innovations, and growth in global aviation traffic. As air travel surges and regulatory demands intensify, the Aircraft MRO Market emerges as an indispensable backbone for sustainable, safe, and efficient aviation. Download Sample
Pharmaceuticals Market is expected to grow a CAGR of 7.1% during 2025-2031
Pharmaceuticals Market is expected to grow a CAGR of 7.1% during 2025-2031
The Global Pharmaceuticals Market 2031 that centers around Pharmaceuticals Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00029839/?utm_source=OpenPR&utm_medium=10607 (Our SAMPLE COPY of the report offers a quick advent to
Orthodontic Equipment Market Poised for 4.8% CAGR Growth by 2031
Orthodontic Equipment Market Poised for 4.8% CAGR Growth by 2031
The Insight Partners is proud to announce its latest research publication, "Orthodontic Equipment Market: An In-depth Analysis of the Orthodontic Equipment Market." This comprehensive report offers a holistic view of the Orthodontic Equipment Market, highlighting the current market dynamics, technological advancements, competitive landscape, and growth forecasts from 2025 to 2031. Overview of Orthodontic Equipment Market- The Orthodontic Equipment Market has experienced steady growth over recent years, primarily driven by the rising prevalence

All 5 Releases


More Releases for MAb

mAb Biosimilars Market Thrives as Cost-effective Alternatives Fuel Adoption | Sa …
mAb Biosimilars Market Overview mAb Biosimilars Market is estimated to grow from USD 9.4 billion in 2025 to USD 22.7 billion by 2032, at a CAGR of 13.3%. Coherent Market Insights is pleased to release its latest mAb Biosimilars Market research report, offering an in-depth analysis of the U.S. mAb Biosimilars Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels, encompassing supply chain shifts, payer-provider
Investigation announced for Investors in I-Mab (NASDAQ: IMAB) concerning potenti …
An investigation was announced for current long-term investors in shares of I-Mab (NASDAQ: IMAB) over potential breaches of fiduciary duties by certain directors at I-Mab . Investors who purchased shares of I-Mab (NASDAQ: IMAB) and currently hold any of those I-Mab (NASDAQ: IMAB shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain I-Mab directors
Anti-PD-1 MAb Market 2020 Size, Share, Comprehensive Research, Significant Porti …
The Anti-PD-1 MAb Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. The immune system has an important ability to differentiate between normal cells in the
Anti-PD-1 MAb Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Anti-PD-1 MAb market analysis, which studies the Anti-PD-1 MAb's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Anti-PD-1 MAb Market 2020-2025” Research Report categorizes the global Anti-PD-1 MAb market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Puzzle Pieces Marketing Lends our Fab President to the MAB
SAN DIEGO, CA - October 23, 2018 - Puzzle Pieces Marketing is excited to announce that our very own, Angel Mason Broadus, is now a part of the Point Loma Nazarene University (PLNU) Marketing Advisory Board (MAB). The MAB is a team of marketing professionals, representing a diverse span of marketing careers and organizations, serving to provide input and direction to the faculty, and opportunities for the students. The formation of
Global mAb Biosimilar Market report in explored in latest research 2022
“Global mAb Biosimilar Market Research Report 2016” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. This report study is on Global MAb Biosimilar market in detail and presents comprehensive forecasts regarding the market’s growth trajectory during the forecast period. The rising disposable income of consumers in emerging economies and the steady technological innovation observed in the Global MAb Biosimilar Market are also anticipated. Moreover, the key drivers supporting and help propelling